8291 (8291) Fair Value & Analysis

Consumer Cyclical · Market cap HK$11.7M

8 8291 8291 · HK

PriceHK$0.2100

Fair ValueHK$1.21

Upside+476.2%

Quality35/100

Watch 8291 for free — get notified when fair value or trend changes. Watch for free

Evidence: Low Range HK$0.9000 – HK$1.51

Fair value as of: Jul 3, 2026

From 6 valuation models · updated today

Share price −31.1% over the past month.

Price vs Fair Value (12 months)

12‑month range HK$0.1890 – HK$0.5000 · fair‑value band HK$0.9000 – HK$1.51 · the HK$0.2100 price screens below the HK$1.21 fair value. As of Jul 3, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

8291 (8291) currently trades at HK$0.2100, while our model-based Fair Value estimate is HK$1.21 — implying the stock looks roughly 476.2% undervalued today. We read business quality at 35/100 (below-average quality), in the Consumer Cyclical sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: low) — always confirm before acting.

Over the trailing twelve months, 8291 generated revenue of HK$45.3M at a net margin of 7.2%. Revenue grew 27.6% year over year. Net debt stands at HK$81.8M. The stock trades on a trailing P/E of 3.1. Fundamentals as of Jul 3, 2026

Key figures & financial health

Revenue (TTM) HK$45.3M

Revenue growth (YoY) +27.6%

Net margin 7.2%

Free cash flow −HK$44.1M FY2025

P/E ratio 3.1

Operating margin -12.1%

More key figures

EPS growth (YoY) -18.8%

Net debt HK$81.8M FY2025

Figures from reported company fundamentals (EODHD) · as of Jul 3, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

8291 reported revenue of HK$45.3M in FY2025 versus HK$45.6M in FY2021, a compound −0.2%/yr. Reported net income was HK$3.3M in FY2025.

Revenue −0.2%/yr

FY21 HK$45.6M

FY22 HK$37.0M

FY23 HK$48.5M

FY24 HK$54.5M

FY25 HK$45.3M

Net income

FY21 −HK$54.7M

FY22 −HK$104M

FY23 −HK$27.0M

FY24 −HK$7.0M

FY25 HK$3.3M

Is 8291 fairly valued? → Check now

Similar stocks

6 more Packaging & Containers stocks, each showing price versus our Fair Value estimate (as of Jul 3, 2026).

Stock	Price	Fair Value	vs Fair Value
Smurfit Kappa Group SMFTF	$44.20	$27.40	-38%
Smurfit Westrock Plc, SW	$38.95	$62.16	+60%
Packaging Corporation PKG	$234.03	$123.93	-47%
International Paper Company IP	$31.85	$48.43	+52%
Amcor plc AMCR	$38.17	$17.00	-55%
Ball Corporation B1LL34	R$141.68	R$105.09	-26%

Explore undervalued stocks

More undervalued Consumer Cyclical stocks →

All undervalued stocks Technology Financial Services Healthcare Consumer Cyclical Consumer Defensive Communication Services Industrials Energy Basic Materials Real Estate Utilities Deeply Undervalued Stocks Undervalued Blue-Chip Stocks Undervalued Small-Cap Stocks

Frequently asked questions

Is 8291 (8291) undervalued?

As of Jul 3, 2026, our model estimates a fair value of HK$1.21 versus a price of HK$0.2100 — about +476% (undervalued). Model-based estimate, not financial advice.

What is the fair value of 8291?

Our model-based fair value for 8291 is HK$1.21 (as of Jul 3, 2026), built from audited fundamentals. The current price is HK$0.2100.

What is the quality score of 8291?

8291 has a Quality Score of 35/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

What is the revenue of 8291 (8291)?

8291 reported trailing-twelve-month revenue of about HK$45.3M (latest available figure, as of Jul 3, 2026).

What is the net profit margin of 8291?

The net profit margin of 8291 is about 7.2%, meaning it keeps roughly 7.2% of revenue as net income. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.